Stockreport

Foamix Announces AMZEEQ™ (minocycline) Topical Foam Available in Pharmacies Nationwide on January 13th for the Treatment of Moderate to Severe Acne

FOAMIX PHARMACEUTICALS LTD  (FOMX) 
Last foamix pharmaceuticals ltd earnings: 11/11 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.foamix.co.il
PDF AMZEEQ is the First FDA Approved Topical Form of Minocycline and the Company’s First Commercial Launch AMZEEQ Offers Efficacy with Low Systemic Absorption [Read more]